CoreCap Advisors
IDYA icon

CoreCap Advisors’s IDEAYA Biosciences IDYA Stock Holding History

CoreCap Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.3K Hold
60
– – ﹤0.01% 2469
2026
Q2 		$2.24K Hold
60
– – ﹤0.01% 2509
2026
Q1 		$2K Hold
60
– – ﹤0.01% 2414
2025
Q4 		$2.07K Buy
+60
New +$1.91K ﹤0.01% 2469

Other funds holding IDYA

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

CoreCap Advisors's IDYA Position: Q3 2026 in Review

CoreCap Advisors held its IDEAYA Biosciences (IDYA) position steady in Q3 2026 at 60 shares worth $2.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2469.

CoreCap Advisors first reported a position in IDYA in Q4 2025 and has held it in 4 quarters since. 29 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • CoreCap Advisors held 60 shares of IDEAYA Biosciences worth $2.3K as of Q3 2026.
  • CoreCap Advisors left its IDEAYA Biosciences share count unchanged in Q3 2026.
  • IDEAYA Biosciences made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2469 holding.
  • CoreCap Advisors first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 4 quarters since.
  • 29 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.